Flora Growth CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Michael Heinrich, Executive Chairman and a Director of Flora Growth Corp., purchased 4,608,575 shares of common stock on July 20, 2026 for $0.75 per share.
Daniel Reis-Faria, CEO and a Director of Flora Growth Corp., reported multiple transactions in common stock on July 20, 2026.
Dany Vaiman, CFO of Flora Growth Corp., received 250,000 shares of common stock on July 20, 2026.
Laurence Zeifman, a Director at ZeroStack Corp., has acquired 28,000 stock options with an exercise price of $5.10, vesting over time.
Edward Woo, a Director at ZeroStack Corp., has acquired 35,000 stock options with an exercise price of $5.10, vesting over time.
Manfred Leventhal, a Director at ZeroStack Corp., acquired 35,000 stock options with an exercise price of $5.10, vesting over time.
Michael Heinrich, Executive Chairman and Director of ZeroStack Corp., reported the settlement of a convertible promissory note with Zero Gravity Labs Inc., a company he controls.
Flora Growth Corp.'s CFO, Dany Vaiman, was granted 235,604 employee stock options with an exercise price of $7.31, vesting over five installments contingent on share price thresholds.
Flora Growth Corp. CEO Daniel Reis-Faria was granted 471,208 performance-based stock options with an exercise price of $7.31, vesting over five installments contingent on the company's volume weighted average price.
Flora Growth Corp.'s Executive Chairman, Michael Heinrich, was granted 471,208 stock options with a $7.31 exercise price, vesting contingent on share price thresholds.
Flora Growth Corp.'s Executive Chairman, Michael Heinrich, is set to acquire a convertible promissory note, exercisable from October 23, 2025, representing 4.9 million common shares through an entity he controls.
Flora Growth Corp. Director Michael John Brown was granted 7,468 Deferred Share Units, increasing his total beneficial ownership to 94,421 DSUs.
Flora Growth Corp.'s CEO, Daniel Reis-Faria, acquired 5,954,743 pre-funded token warrants, exercisable upon future shareholder approval.
Flora Growth Corp. director Harold Wolkin's Stock Appreciation Rights (SARs) were amended with shareholder approval, reducing the exercise price from $1.30 to $0.58 for 30,000 shares.
Flora Growth Corp. director Manfred Leventhal's Stock Appreciation Rights (SARs) were amended with shareholder approval, lowering their exercise price from $1.30 to $0.58.
Flora Growth Corp. CEO Clifford Starke's Stock Appreciation Rights (SARs) were amended with shareholder approval to significantly lower their exercise prices, impacting over 1.6 million underlying common shares.
Flora Growth Corp.'s Chief Financial Officer, Dany Vaiman, had his Stock Appreciation Rights (SARs) repriced to a lower exercise price with shareholder approval, as detailed in a recent SEC Form 4 filing.
Director Edward Woo of Flora Growth Corp. reports the acquisition of 50,000 common shares and the disposal of 2,021 common shares held indirectly.
Harold Wolkin, a director at Flora Growth Corp., acquired 30,000 stock appreciation rights (SARs) on December 15, 2024.
Flora Growth Corp.'s CFO, Dany Vaiman, acquired 372,500 stock appreciation rights (SARs) on December 15, 2024.
Flora Growth Corp. CEO Clifford Starke acquired 900,000 common shares on December 15, 2024, increasing his direct holdings.
Manfred Leventhal, a director at Flora Growth Corp., acquired 5,000 stock appreciation rights (SARs) on December 15, 2024.
Executive Chairman of Flora Growth Corp., Sammy Dorf, acquired 250,000 restricted shares on December 15, 2024.
CEO Clifford Starke reports purchasing additional common shares and transferring shares to YT Research, Inc., a company he controls.
Harold Wolkin, a director of Flora Growth Corp., recently acquired 25,000 common shares through a series of open market purchases.
Flora Growth Corp.'s CFO, Dany Vaiman, reports the acquisition of stock appreciation rights (SARs) in two separate transactions.
Clifford Starke, CEO of Flora Growth Corp., reports acquisition of common shares and stock appreciation rights (SARs).
Flora Growth Corp.'s CEO, Clifford Starke, reports acquiring 526,315 common shares at $1.90 on April 8, 2024, and discloses beneficial ownership of shares held indirectly through various entities.